Logo image of MRX.DE

MISTER SPEX SE (MRX.DE) Stock Fundamental Analysis

FRA:MRX - Deutsche Boerse Ag - DE000A3CSAE2 - Common Stock - Currency: EUR

1.5  -0.05 (-3.23%)

Fundamental Rating

3

Overall MRX gets a fundamental rating of 3 out of 10. We evaluated MRX against 54 industry peers in the Specialty Retail industry. While MRX seems to be doing ok healthwise, there are quite some concerns on its profitability. MRX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MRX had negative earnings in the past year.
In the past year MRX has reported a negative cash flow from operations.
MRX had negative earnings in each of the past 5 years.
In multiple years MRX reported negative operating cash flow during the last 5 years.
MRX.DE Yearly Net Income VS EBIT VS OCF VS FCFMRX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

With a Return On Assets value of -23.46%, MRX is not doing good in the industry: 83.02% of the companies in the same industry are doing better.
MRX has a Return On Equity of -44.25%. This is in the lower half of the industry: MRX underperforms 75.47% of its industry peers.
Industry RankSector Rank
ROA -23.46%
ROE -44.25%
ROIC N/A
ROA(3y)-14.03%
ROA(5y)-11.64%
ROE(3y)-22.01%
ROE(5y)-25.74%
ROIC(3y)N/A
ROIC(5y)N/A
MRX.DE Yearly ROA, ROE, ROICMRX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

With an excellent Gross Margin value of 52.57%, MRX belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
MRX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for MRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y1.76%
MRX.DE Yearly Profit, Operating, Gross MarginsMRX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

MRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MRX has more shares outstanding
MRX has a worse debt/assets ratio than last year.
MRX.DE Yearly Shares OutstandingMRX.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
MRX.DE Yearly Total Debt VS Total AssetsMRX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.52, we must say that MRX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.52, MRX is doing worse than 71.70% of the companies in the same industry.
MRX has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
MRX has a better Debt to Equity ratio (0.49) than 60.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC4.82%
MRX.DE Yearly LT Debt VS Equity VS FCFMRX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 3.04 indicates that MRX has no problem at all paying its short term obligations.
The Current ratio of MRX (3.04) is better than 90.57% of its industry peers.
MRX has a Quick Ratio of 2.24. This indicates that MRX is financially healthy and has no problem in meeting its short term obligations.
MRX has a Quick ratio of 2.24. This is amongst the best in the industry. MRX outperforms 92.45% of its industry peers.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.24
MRX.DE Yearly Current Assets VS Current LiabilitesMRX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for MRX have decreased strongly by -20.77% in the last year.
The Revenue has been growing slightly by 1.30% in the past year.
MRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.73% yearly.
EPS 1Y (TTM)-20.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.86%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y10.83%
Revenue growth 5Y12.73%
Sales Q2Q%-3.17%

3.2 Future

Based on estimates for the next years, MRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.50% on average per year.
MRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.66% yearly.
EPS Next Y-86.57%
EPS Next 2Y-2.37%
EPS Next 3Y10.5%
EPS Next 5YN/A
Revenue Next Year-2.59%
Revenue Next 2Y-0.35%
Revenue Next 3Y1.21%
Revenue Next 5Y8.66%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MRX.DE Yearly Revenue VS EstimatesMRX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MRX.DE Yearly EPS VS EstimatesMRX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRX.DE Price Earnings VS Forward Price EarningsMRX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRX.DE Per share dataMRX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.37%
EPS Next 3Y10.5%

More info and screens

0

5. Dividend

5.1 Amount

MRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MISTER SPEX SE

FRA:MRX (3/7/2025, 7:00:00 PM)

1.5

-0.05 (-3.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2024-05-08/amc
Earnings (Next)N/A N/A
Inst Owners25.4%
Inst Owner ChangeN/A
Ins Owners3.98%
Ins Owner ChangeN/A
Market Cap52.58M
Analysts77.5
Price Target4.93 (228.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.19%
PT rev (3m)-7.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.84%
EPS NY rev (3m)-19.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-1.65
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS6.37
BVpS3.56
TBVpS2.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.46%
ROE -44.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.57%
FCFM N/A
ROA(3y)-14.03%
ROA(5y)-11.64%
ROE(3y)-22.01%
ROE(5y)-25.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y1.76%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.75%
Cap/Sales 3.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.04
Quick Ratio 2.24
Altman-Z -0.52
F-Score4
WACC4.82%
ROIC/WACCN/A
Cap/Depr(3y)72.39%
Cap/Depr(5y)88.93%
Cap/Sales(3y)8.02%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.86%
EPS Next Y-86.57%
EPS Next 2Y-2.37%
EPS Next 3Y10.5%
EPS Next 5YN/A
Revenue 1Y (TTM)1.3%
Revenue growth 3Y10.83%
Revenue growth 5Y12.73%
Sales Q2Q%-3.17%
Revenue Next Year-2.59%
Revenue Next 2Y-0.35%
Revenue Next 3Y1.21%
Revenue Next 5Y8.66%
EBIT growth 1Y-25.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.67%
EBIT Next 3Y37.17%
EBIT Next 5Y28.78%
FCF growth 1Y48.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.05%
OCF growth 3YN/A
OCF growth 5YN/A